Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
INO Inovio Pharmaceuticals
1.790
-0.060-3.24%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Revenue under collaborative research and development arrangements--902.26K50.84%
Other revenue--627.19K35.34%
Revenue under collaborative research and development arrangements from affiliated entities--245.31K13.82%
Region Unit:USD
nameYOYOperating income%
United States--1.77M100.00%
Company Overview More
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
CEO: Dr. Jacqueline E. Shea
Market: NASDAQ
Listing Date: 12/08/1998
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist